Platelet Inhibition Agents: Current and Future P2Y12 Receptor Antagonists

By  

Current Vascular Pharmacology, Vol. 13, Iss. 5, 2015-01 ,pp. : 566-577

Bentham Science Publishers

Access to resources Recommend Favorite

Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y₁ receptor in vitro

By Maayani Saul   Schwarz Todd E.   Patel Nayana D.   Craddock-Royal Barbara D.   Tagliente Thomas M.  

Platelets, Vol. 14, Iss. 7-8, 2003-11 ,pp. : 445-462

Informa Healthcare

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses

By Judge Heather M.   Buckland Robert J.   Holgate Carol E.   Storey Robert F.  

Platelets, Vol. 16, Iss. 7, 2005-11 ,pp. : 398-407

Informa Healthcare

Access to resources Recommend Favorite

Effects of P2Y₁ and P2Y₁₂ receptor antagonists on platelet aggregation induced by different agonists in human whole blood

By Storey Robert F.   Newby Linda J.   Heptinstall Stan  

Platelets, Vol. 12, Iss. 7, 2001-11 ,pp. : 443-447

Informa Healthcare

Access to resources Recommend Favorite

Future Prospects in Anti-Platelet Therapy: A Review of Potential P2Y12 and Thrombin Receptor Antagonists

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 194-200

Bentham Science Publishers

Access to resources Recommend Favorite